1. Home
  2. PRAX vs XPEL Comparison

PRAX vs XPEL Comparison

Compare PRAX & XPEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRAX
  • XPEL
  • Stock Information
  • Founded
  • PRAX 2015
  • XPEL 1999
  • Country
  • PRAX United States
  • XPEL United States
  • Employees
  • PRAX N/A
  • XPEL N/A
  • Industry
  • PRAX Biotechnology: Pharmaceutical Preparations
  • XPEL Industrial Specialties
  • Sector
  • PRAX Health Care
  • XPEL Industrials
  • Exchange
  • PRAX Nasdaq
  • XPEL Nasdaq
  • Market Cap
  • PRAX 1.4B
  • XPEL 1.2B
  • IPO Year
  • PRAX 2020
  • XPEL N/A
  • Fundamental
  • Price
  • PRAX $74.49
  • XPEL $41.35
  • Analyst Decision
  • PRAX Strong Buy
  • XPEL Buy
  • Analyst Count
  • PRAX 9
  • XPEL 2
  • Target Price
  • PRAX $149.00
  • XPEL $49.00
  • AVG Volume (30 Days)
  • PRAX 388.8K
  • XPEL 126.4K
  • Earning Date
  • PRAX 03-04-2025
  • XPEL 02-26-2025
  • Dividend Yield
  • PRAX N/A
  • XPEL N/A
  • EPS Growth
  • PRAX N/A
  • XPEL N/A
  • EPS
  • PRAX N/A
  • XPEL 1.75
  • Revenue
  • PRAX $1,605,000.00
  • XPEL $418,411,000.00
  • Revenue This Year
  • PRAX N/A
  • XPEL $8.08
  • Revenue Next Year
  • PRAX N/A
  • XPEL $13.97
  • P/E Ratio
  • PRAX N/A
  • XPEL $23.63
  • Revenue Growth
  • PRAX N/A
  • XPEL 13.32
  • 52 Week Low
  • PRAX $33.01
  • XPEL $30.75
  • 52 Week High
  • PRAX $91.83
  • XPEL $60.49
  • Technical
  • Relative Strength Index (RSI)
  • PRAX 42.80
  • XPEL 46.89
  • Support Level
  • PRAX $76.00
  • XPEL $41.41
  • Resistance Level
  • PRAX $91.83
  • XPEL $43.60
  • Average True Range (ATR)
  • PRAX 6.29
  • XPEL 1.34
  • MACD
  • PRAX -1.10
  • XPEL -0.01
  • Stochastic Oscillator
  • PRAX 2.42
  • XPEL 47.90

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.

About XPEL XPEL Inc.

XPEL Inc is a provider of protective films and coatings, including automotive paint protection film, surface protection film, automotive and commercial/residential window films, and ceramic coatings. The company has a network of trained installers and proprietary DAP software, dedicated to exceeding customer expectations by providing quality products, customer service, technical support, and world-class training. The majority of revenue is derived from the United states.

Share on Social Networks: